The immunoassay segment accounts about 35% of the market, with no growth compared to the previous year. Domestic brands account for over 35%.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

After you finish a milkshake or a bowl of guacamole, those dietary fats have a typical route through your body. New research from the laboratory of Dr. Natasza Kurpios, has now revealed a key molecular mechanism.

LumiraDx said on Thursday that it has received CE marking for its point-of-care SARS-CoV-2 & Flu A/B Antigen Test.

Quidel Corporation (NASDAQ: QDEL) (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho”) today announced that they have entered into a definitive agreement in which Quidel will acquire Ortho

On December 15th, Ministry of Science and Technology of the People’s Republic of China announce the list of advanced collectives in the national science and technology system for fighting COVID-19 epidemic.

Co-Diagnostics said on Wednesday that it has signed definitive agreements to acquire privately held biotech firms Idaho Molecular and Advanced Conceptions for nearly $50 million in stock and warrants.

Mutations of the gene MLL4 in epithelial skin cells can inhibit healthy cell turnover and may lead to keratinocyte cancers, which collectively outnumber all other human cancers.

On December 20, the 23rd (2020) China Securities Journal Golden Bull Awards for listed companies were officially announced, with 350 companies sharing seven Golden Bull Awards!

GE today announced that it has completed its previously announced acquisition of BK Medical, a leader in advanced surgical visualization, from Altaris Capital Partners, LLC.

Drugs developed to treat AIDS and HIV could offer hope to patients diagnosed with the most common form of primary brain tumour.

FIND announced on Monday that it is investing $21 million in four companies to develop and launch point-of-care molecular diagnostic platforms for infectious diseases.